Small Beer Brewing Company specialises in brewing classic beer with an Alcohol By Volume (ABV) below 2.8% without any loss in flavour. The company asserts that the beer market is worth £18.4 billion in the UK and over £520 billion globally. In the UK, the 'Low & No' category sits at £450 million. The company aims to be a major contender in this category. It is already exporting its products to Iceland, Singapore, Hong Kong & Spain. The company's stockists include entities like Majestic Wine, Ocado and Waitrose. It will use the investment to fund its expansion both in the UK & foreign markets.
days to go:
Expired
investment:
£750,004
C-Major is a medical technology company. It asserts that over 2 million people suffer a Needle Stick Injury (NSI) every year and are at risk of contracting blood-borne viruses such as Hepatitis and HIV. It aspires to resolve this crisis by bringing to market its patented medical device, Controlled Helical Retraction Device, to prevent NSIs. The company argues that the device contains a ‘Helical Track’ mechanism for controlled acceleration of the needle during retraction as well as a ‘Sealed Port’ to minimise any blood splatter. C-Major endeavours to disrupt the $5.5 billion safety syringe market with its product. It is backed by the UK 'Innovation Seed' fund. C-Major will use the investment to complete the final design of its product for manufacture and assembly ahead of a Series A funding round in 2021.
days to go:
Expired
investment:
£211,595
Drop Bear Beer Co. is a specialist brewer of less than 0.5% craft beers. The company asserts that its products are vegan, gluten-free, and low in calories. It has brewed over 160,000 bottles to date. Drop Bear argues that the Global Non-Alcoholic Drinks market was valued at $18 billion in 2020. It aims to be a significant contender in the segment. The company's products are available in six global markets. Drop Bear has won awards ranging from a World Beer Award to a Great British Entrepreneur Award. The company will use the investment to expand its team and build a second dedicated alcohol-free brewery in the UK.
days to go:
Expired
investment:
£325,000
Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.
days to go:
Expired
investment:
£270,543
Living With is a health technology company offering a pocket-friendly and simple patient management application that allows medical professionals treat and track patients remotely. The app aims to revolutionise the way doctors and hospitals access digital tools to treat patients while collecting data for medical device and pharma companies. The company owns Squeezy (a popular paid medical app in the UK) and already has five products in 17 NHS Trusts. Living With also has a contract with one of the world’s greatest medical device companies. Living With will use the proceeds to give 5 data (drug/device) and 50 access customers (clinic/doctor), become HIPAA compliant for the US and to quicken sales and marketing.
days to go:
Expired
investment:
£200,000
MedicSpot is a healthcare company that is aiming to revolutionise healthcare delivery by combining the advantages of online and offline care. The company provides patients at designated hospitals with diagnostic tools like a stethoscope, oximeter, blood pressure monitor and thermometer which, in turn, is connected to the MedicSpot network. Onboard General Physicians (GPs) engage in live sessions with patients, guide them on how to use the tools, and perform a variety of diagnoses like listening to a patient’s heart and lungs, looking down their throat and into their ears, taking their blood pressure and oxygen readings, and measuring their body temperature. The company is also expanding into another subsidiary, Arc Health, which it claims will perform the aforementioned tasks with more efficiency and accuracy. The company will use the investment to increase the number of Medicspot clinics to 1,000, gain further NHS market share, launch a corporate business model and allow international pilots to take place.
days to go:
Expired
investment:
£1,048,396
gowithYamo aims to make art more accessible to everyone, from art newbies to experienced gallery-goers through its application. Users can collect Yamo points by checking-in to galleries and exchanging them for rewards such as art prints and exhibition tickets from the company's in-app store. gowithYamo provides support to galleries, museums and artists by exposing them to an active community of art lovers. The company also offers custom-built virtual exhibition spaces where artists can show and sell their work to a sizeable digital audience. gowithYamo has collaborated with art entities like Roy's Art Fair, The Other Art Fair, Harlesden High Street, and many others. It has a social media presence of 50,000+ followers. The company will use 30% of the investment to expand across different demographics, 25% to further finetune its virtual exhibition platform, 20% for marketing, and 25% to implement Artificial Intelligence (AI) in the gowithYamo app to help recommend exhibitions to its users.
days to go:
Expired
investment:
£161,105
HUUB is a premium endurance sports apparel brand. Its products are used by Olympic gold medallists, 'IRONMAN' champions and amateur athletes. HUUB witnessed profits worth £4.8 million and an EBITDA of £420,000 in 2019. The company is a leading brand in the £60 million UK triathlon apparel & accessories market. HUBB is now targeting the US$5 billion global bike apparel market. It has built working relationships with noteworthy individuals such as former Olympian Greg Whyte and chef Gordon Ramsay. The company will use the investment to target all endurance sports through a combination of retail and distributor partnerships. It will also expand its Direct-To-Consumer (DTC) online business.
days to go:
Expired
investment:
£1,352,941
West Berkshire Brewery is a beer manufacturer on a mission to deliver best-in-class beers, from heritage styles to modern craft beers, to its customers. Its products are on the shelves of UK supermarkets including Waitrose, Tesco and the Co-Op. The company can scale up to 26 million pints per annum thanks to its modern brewery units that are equipped with bottling and canning lines technologies along with the option of cold storage. Its brewery consists of a 200-capacity 'Taproom & Kitchen', a destination venue that generates a revenue of £1.4 million per annum. It will utilise the investment to support the installation and commissioning of its 'Fridge Pack Machine', support marketing initiatives with its pub partners across the South of England, and provide capital to enable any pub acquisition opportunities as they arise over the coming year.
days to go:
Expired
investment:
£1,390,948
Pass the Keys is a leading short-let tech platform operating in 20 cities across the UK. Till date, the company has hosted 30,000+ guests and earned £15 million for its hosts. The company lists a landlord's property on appropriate portals, finds relevant guests for an event or function, looks after their needs, and even takes care of cleaning up the venue after an event. The company's end-to-end technology automates the majority of the tasks such as job scheduling, invoicing, calendar syncing, and pricing with reliable support staff ready to assist with any eventuality. The company has achieved good ratings on Google reviews, Trustpilot and Glassdoor. The company will use 50% of the investment to expand its franchise, 30% for product development, and 20% for training personnel and supporting infrastructure.
days to go:
Expired
investment:
£1,069,632
